CN105572347A - Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim - Google Patents

Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim Download PDF

Info

Publication number
CN105572347A
CN105572347A CN201410552523.7A CN201410552523A CN105572347A CN 105572347 A CN105572347 A CN 105572347A CN 201410552523 A CN201410552523 A CN 201410552523A CN 105572347 A CN105572347 A CN 105572347A
Authority
CN
China
Prior art keywords
carbendazim
solution
chemical luminescence
detection kit
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410552523.7A
Other languages
Chinese (zh)
Inventor
洪霞
杜霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian Chuan Bio Tech Ltd Zhenjiang
Original Assignee
Xian Chuan Bio Tech Ltd Zhenjiang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian Chuan Bio Tech Ltd Zhenjiang filed Critical Xian Chuan Bio Tech Ltd Zhenjiang
Priority to CN201410552523.7A priority Critical patent/CN105572347A/en
Publication of CN105572347A publication Critical patent/CN105572347A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a chemiluminiscence enzyme-linked immunoassay kit for carbendazim. The chemiluminiscence enzyme-linked immunoassay kit comprises a kit body, an elisa plate and reagents arranged in the kit body. The chemiluminiscence enzyme-linked immunoassay kit is characterized in that each hole of the elisa plate is coated with a coating antigen, that is, a conjugate of carbendazim mother nuclei and carrier protein, and the reagents comprise a carbendazim monoclonal antibody, a horseradish peroxidase-marked goat-anti-mouse antibody, a carbendazim series standard solution, a concentrated phosphate buffer solution, a concentrated washing solution and a chemiluminiscence solution. The chemiluminiscence enzyme-linked immunoassay kit has the advantages of being high in sensitivity, simple, convenient, rapid, high in accuracy and more in detected drug category, and the operation time is significantly shortened compared with a traditional colorimetric ELISA method; the method can be directly used for detecting the content of carbendazim in vegetables and plants.

Description

A kind of chemiluminescence enzyme-linked immunoassay detecting carbendazim
Technical field
The present invention relates to a kind of enzyme-linked immunologic detecting kit, particularly relate to a kind of chemical luminescence ELISA detection kit of carbendazim.
Background technology
Carbendazim (Carbendazin), chemical name 2-(methoxyformamido) benzimidazole [2-(methoxy-carbanmoyl)-benzimidaxole], be a kind of high-efficiency low-toxicity germifuge, can be used for preventing and treating plurality of plant diseases.Carbendazim is a kind of agricultural chemicals conventional in vegetable growing process, and China's victual export volume is very large, and residues of pesticides are very important restriction indexs.Therefore regularly carbendazim is remained to the necessary means detecting the monitoring becoming many countries.European Union specifies that the maximum residue limit(MRL) of carbendazim in vegetables (MRL) is 0.1mg/kg.
At present, the method detecting carbendazim mainly contains: high performance liquid chromatography (HPLC), look/matter combination analysis method (LC-MS), liquid/matter combination analysis method (LC-MS/MS).The defect of thin-layered chromatography is: operating process is complicated, and the time is long; Operating personnel need through professional training; The disturbing factor of impact analysis is more, result poor repeatability.Radioimmunology, high performance liquid chromatography, look/matter are used in conjunction analytic approach, the defect of liquid/these physico-chemical methods of matter combination analysis method is that instrument and equipment is expensive, sample pre-treatments is complicated, time-consuming, effort, not easily popularize, testing cost is high, particularly radioimmunology also needs to be equipped with radioactive source, has certain risk.Given this, the method setting up carbendazim content in a kind of effective, quick, simple, sensitive detection vegetable plant is significant.
Summary of the invention
The object of this invention is to provide a kind of chemical luminescence ELISA detection kit of carbendazim.This kit has that detection sensitivity is high, applying flexible, easily feature.
The chemical luminescence ELISA detection kit of carbendazim of the present invention, comprise box body, be located at ELISA Plate in box body and be located at carbendazim series standard solution in box body, enzyme mark goat anti-rabbit antibody, carbendazim antibody, luminescent solution, wash solution, bag by solution and lock solution; It is characterized in that:
Each hole of described ELISA Plate is coated with the envelope antigen made with carbendazim and ovalbumin coupling, wherein envelope antigen concentration preferably 10 μ g/mL.
Preferred 6.7KDa ~ the 6.8KDa of molecular weight ranges of described ovalbumin.
Described carbendazim series standard solution is that described in 0mg/kg, 0.01mg/kg, 0.03mg/kg, 0.09mg/kg, 0.27mg/kg and 0.81mg/kg, enzyme mark goat anti-rabbit antibody is horseradish peroxidase-goat anti-rabbit igg stoste respectively, and its working concentration is preferably 1:1000.
Described carbendazim antibody is the obtained polyclonal antibody of the bovine serum albumin coupling being 6.7KDa ~ 6.8KDa by carbendazim and the molecular weight ranges artificial immunogen immune animal of making, and its working concentration is preferably 1:1000.
Described luminescent solution is three (methylol) aminomethane solution (pH=8.8) and 3/10000 (volume ratio) H of 0.01M luminol and 0.001M p-cresol 2o 2mixed liquor.Described luminol is luminous substrate, and p-cresol is luminescence enhancer.
Described wash solution is pH7.5,0.1mol/L phosphate buffer containing volume fraction 0.05% Tween-20.
Described bag is the solution containing 1.59g sodium carbonate and 2.53g sodium bicarbonate in every premium on currency by solution, and pH is 9.5.
Described lock solution contains 10g ovalbumin (OVA, ovalbumin, also claim chicken ovalbumin or chicken ovalbumin, be made up of 386aa, molecular weight is about 43Kd) in often liter of wash solution and adds weight fraction 0.5%NaN 3solution.
Kit maximum detection range of the present invention is 0.01mg/kg ~ 0.81mg/kg.
The sensitivity impact that the carbendazim standard solution related in kit of the present invention, enzyme mark goat anti-rabbit antibody solution, carbendazim antibody-solutions, luminescent solution and wash solution and formula thereof detect kit of the present invention is very large; Wherein the principal ingredient of each solution and compound method thereof are:
1, carbendazim standard solution: compound concentration is respectively 0mg/kg in conventional manner, the carbendazim standard solution of 0.01mg/kg, 0.03mg/kg, 0.09mg/kg, 0.27mg/kg and 0.81mg/kg;
2, enzyme mark goat anti-rabbit antibody solution: enzyme mark goat anti-rabbit antibody is horseradish peroxidase-goat anti-rabbit igg stoste, is mixed with the working concentration of 1:1000 during use with wash solution;
3, carbendazim antibody-solutions: carbendazim antibody is with the obtained polyclonal antibody of artificial immunizing antigen immune animal, gained carbendazim antibody wash solution is diluted to the working concentration of 1:1000;
4, luminescent solution: three (methylol) aminomethane solution (pH=8.8) and 3/10000 (volume ratio) H of being 0.01M luminol and 0.001M p-cresol 2o 2mixed liquor;
5, wash solution: refer to pH7.5,0.1mol/L phosphate buffer containing volume fraction 0.05% Tween-20;
6, wrap by solution: 1.59g sodium carbonate and 2.53g sodium bicarbonate are dissolved in 1L water, regulate pH to be 9.5;
7, lock solution preparation: 10gOVA is dissolved in 1L wash solution, then adds the NaN that weight ratio is 0.05% 3.
The preparation of ELISA Plate of the present invention:
The method for coating of ELISA Plate of the present invention adopts carbendazim-OVA at the bag of setting by solution, with the concentration set, and reaction overnight bag quilt in 4 DEG C.
The present invention adopt to be pH be 9.5 sodium carbonate-bicarbonate buffer solution.In ELISA Plate of the present invention, the carbendazim-ovalbumin (OVA) of institute's bag quilt can well be combined on microwell plate frosting under alkaline environment, can stand repeatedly to wash plate, and the envelope antigen concentration of employing is 10 μ g/mL.
Bag can be closed by lock solution by good ELISA Plate, and in confining liquid, the preferred ovalbumin of inert protein (OVA), need add NaN 3prevent from going bad.
The preparation of carbendazim antibody-solutions and enzyme mark goat anti-rabbit antibody solution:
In the present invention, carbendazim antibody-solutions, enzyme mark goat anti-rabbit antibody solution concentration are the key factors determining Ractopamine enzyme linked immunological test kit measurement range and sensitivity in the present invention.
It is 0.01 ~ 0.81mg/kg solution that the carbendazim antibody-solutions related in the present invention can be mixed with concentration with wash solution; Or the working concentration of 1:1000 is diluted to wash solution.
The enzyme mark goat anti-rabbit antibody solution related in the present invention preferably with wash solution preparation concentration be 1:1000.
The kit prepared according to above-mentioned carbendazim antibody-solutions concentration and enzyme mark goat anti-rabbit antibody solution concentration can reach the good range of linearity (standard lines scope can reach 0.01mg/kg ~ 0.81mg/kg) and good detectability (0.05mg/kg).
The preparation of luminescent solution:
The present invention adopts horseradish peroxidase labeled substrate luminescent system, mainly luminol-hydrogen peroxide system.
Described luminescent solution is three (methylol) aminomethane solution (pH=8.8) and 3/10000 (volume ratio) H of 0.01M luminol and 0.001M p-cresol 2o 2mixed liquor.Described luminol is luminous substrate, and p-cresol is luminescence enhancer.
Principle of the present invention is combined with enzymatic high sensitivity by the high degree of specificity that antibody-antigene reacts, and utilizes the chemiluminescence reaction of substrate for enzymatic activity to detect production concentration.
Chemical luminescence ELISA detection kit of the present invention has highly sensitive, easy point fast and accurately, compares with traditional colorimetric ELISA method, and sensitivity can improve an order of magnitude.Be expected to play a significant role in the carbendazim residue detection in crop products.
Accompanying drawing explanation
Fig. 1 is the canonical plotting of carbendazim.
Embodiment
Embodiment 1, immunogene, envelope antigen and the preparation of antibody
(1) immunogenic synthesis
Adopt p-aminobenzoic acid method to carry out coupling carbendazim and bovine serum albumin (BSA) and obtain immunogene.Specifically comprise the following steps:
A, take 14mg (100 μm of ol) p-aminobenzoic acid (ABA) and dissolve in 1.5mL0.2M hydrochloric acid, then take the sodium nitrite (NaNO of 8.3mg (120 μm of ol) 2) be dissolved in the distilled water of 0.24mL, 0-4 DEG C of stirrings, by sodium nitrite (NaNO 2) dropwise joins in p-aminobenzoic acid solution, lucifuge reacts 1 hour, obtains solution A;
B, take 34mg (100 μm of ol) carbendazim be dissolved in 5mL ice-cold borax buffering (0.05M) (pH8.5, NaCl containing 0.15M) in, 0-4 DEG C of stirring, above-mentioned solution A 2mL is dropwise joined in this solution, lucifuge reacts 2 hours, obtains orange solution;
C, solution is added a small amount of boric acid crystal adjust pH to 7.4, then 136mg (2 μm of ol) cBSA (bovine serum albumin(BSA)) is added, add 160mg (834 μm of ol) water-soluble carbodiimide (EDC) simultaneously, 48mg (417 μm of ol) N-hydroxy-succinamide (NHS), stirring at room temperature 3 hours, obtains orange solution;
D, reactant liquor is transferred in semi-permeable diaphragm, dialyse 3 days by phosphate buffered solution (PBS) (0.01M, pH7.4) at 0-4 DEG C, often within 4-6 hour, change a dislysate therebetween; Dialyse 3 days with high purity water subsequently, often within 4-6 hour, change a dislysate therebetween; Dialyse complete, use freeze drier freeze-drying, obtain yellow orange solid powder and be immunogene (conjugate of carbendazim and bovine serum albumin) ,-20 DEG C of preservations, for subsequent use.
(2) synthesis of envelope antigen
Adopt Isosorbide-5-Nitrae-Ding diether method to carry out coupling carbendazim and ovalbumin (OVA) and obtain envelope antigen.Specifically comprise the following steps:
A. taking 66mg ovalbumin (OVA) is dissolved in 5mL50mM carbonate (pH10.7) damping fluid, then in solution, add 1 of 28 μ L (147.9 μm of ol), 4-fourth diether (BDE), room temperature reaction 24 hours, obtains solution A;
B. taking 76mg (277.1 μm of ol) carbendazim is dissolved in 1mlDMF (anhydrous N-N dimethyl formamide), add in 1mL50mM carbonate (pH10.7) damping fluid again, solution A is passed into nitrogen, subsequently carbendazim solution is dropwise added in solution A, room temperature reaction 24 hours, obtains yellow solution;
C. reactant liquor is transferred in semi-permeable diaphragm, dialyse 3 days by phosphate buffered solution (PBS) (0.01M, pH7.4) at 0-4 DEG C, often within 4-6 hour, change a dislysate therebetween; Dialyse 3 days with high purity water subsequently, often within 4-6 hour, change a dislysate therebetween; Dialyse complete, use freeze drier freeze-drying, obtain white solid powder and be envelope antigen (conjugate of carbendazim and ovalbumin) ,-20 DEG C of preservations, for subsequent use.
(3) preparation of carbendazim polyclonal antibody
Adopt new zealand white rabbit as immune animal, be the conjugate of the bovine serum albumin of 6.7KDa ~ 6.8KDa with carbendazim and molecular weight ranges be immunogene, first immunisation dosage is 500 μ g/mL, when head exempts from, immunogene is dissolved in and makes emulsifying agent into isopyknic physiological saline and Freund's complete adjuvant, nape portion multi-point injection, later immunity is got the immunogene that dosage reduces by half and is dissolved in isopyknic physiological saline and incomplete Freund's adjuvant mixing and emulsifying, head exempts from and two exempts from interval 20 days, once be total to immunity five times every immunity in two weeks later, do not add adjuvant for the last time.Culling heart blood after last immune 7 days, centrifugal antiserum, obtains carbendazim polyclonal antibody.
The foundation of embodiment 2, carbendazim-ELISA detection method
(1) preferred (square formation) of antibody and envelope antigen concentration
Longitudinally with the dilution series coated elisa plate of often kind of envelope antigen by 40.0 μ g/mL, 20.0 μ g/mL, 10.0 μ g/mL, 5.0 μ g/mL, 2.5 μ g/mL, 1.25 μ g/mL, 0.625 μ g/mL, 0.3125 μ g/mL, 100 μ L/ holes, 0-4 DEG C of placement is spent the night, wash plate three times with cleansing solution, pat dry at every turn; 250 μ L/ hole lock solution are closed, and room temperature places 2 hours, washes plate three times, pats dry at every turn; Add the antibody (1:100 to 1:1024000) of the 100 a series of dilutions in μ L/ hole, room temperature places 2.5 hours, washes plate three times, pats dry at every turn; Add the horseradish peroxidase-goat anti-rabbit igg antibody of the 1:1000 in 100 μ L/ holes, room temperature places 1 hour, washes plate three times, pats dry at every turn; Add the luminescent solution in 100 μ L/ holes, measure luminous value.The envelope antigen concentration of obvious graded and antibody dilution is had to carry out specific assay for optium concentration with luminous value with the concentration of envelope antigen.
(2) mensuration of antibody sensitivity
According to the optimization experiment of above-mentioned antagonist and envelope antigen concentration, applicant selects and determines that antibody concentration is 1:1000, and envelope antigen concentration is the mensuration that 10 μ g/mL carry out the sensitivity of antibody:
A, bag quilt: the solution by solution, the envelope antigen of carbendazim being made into 10 μ g/mL with the carbonate bag of 0.05MpH9.6, add 100 μ L in the reacting hole of each polystyrene board, 4 DEG C are spent the night;
Next day, discard solution in hole, wash 3 times with lavation buffer solution, 300 μ L/ holes, each 5 minutes, pat dry; (this step is called for short washing, lower same);
B, close: close above-mentioned ELISA Plate of having wrapped quilt by lock solution, 250 μ L/ holes, room temperature incubates 2-4 hour, then washs;
C, application of sample: add the carbendazim solution 50 μ L/ hole of dilution carbendazim antibody (1:1000) 50 μ L/ hole and variable concentrations in the above-mentioned reacting hole closed, room temperature 2-4 hour, then washs;
D, add enzyme labelled antibody: in each reacting hole, add antibody (1:1000) the 100 μ L/ hole of diluted fresh horseradish peroxidase-goat anti-rabbit igg, 1.5 hours, washing;
E, luminescence: the luminescent solution 100 μ L/ hole adding Extemporaneous in each reacting hole, detect with chemical illumination immunity analysis instrument immediately;
F, testing result calculate with inhibiting rate:
Inhibiting rate (%)=B/Bo%, B is the luminous value of medicine as rival of variable concentrations, and Bo is the luminous value of not dosing, and the concentration calculating medicine during 50% inhibiting rate is the sensitivity of this antibody.
The chemiluminescence enzyme linked immunoassay reagent kit of embodiment 3, detection carbendazim
(1) composition of the chemiluminescence enzyme linked immunoassay reagent kit of carbendazim is detected
A, be coated with the solid phase carrier (ELISA Plate) of envelope antigen (conjugate of carbendazim and carrier protein);
B, carbendazim standard solution: 0mg/kg, 0.01mg/kg, 0.03mg/kg, 0.09mg/kg, 0.27mg/kg and 0.81mg/kg;
C, enzyme mark goat anti-rabbit antibody solution: enzyme mark goat anti-rabbit antibody is horseradish peroxidase-goat anti-rabbit igg stoste, load, be mixed with the working concentration of 1:1000 during use with wash solution;
D, carbendazim antibody-solutions: the polyclonal antibody preparing gained with artificial immunizing antigen immune animal, be diluted to 1:1000 working concentration by gained carbendazim antibody wash solution;
E, luminescent solution: use three (methylol) aminomethane solution preparation of 0.0001M p-cresol of pH8.8 to become the luminol solution of 0.01M, then with H 2o 2mix according to the volume ratio of 3:10000;
F, wash solution: pH7.5,0.1mol/L phosphate buffer containing volume fraction 0.05% Tween-20;
G, wrap by solution: 1.59g sodium carbonate and 2.53g sodium bicarbonate are dissolved in 1L water, regulate pH9.5;
H, lock solution are prepared: 10g ovalbumin (OVA) is dissolved in 1L wash solution, then adds the NaN that weight ratio is 0.05% 3.
(2) preparation of ELISA Plate
With coating buffer, envelope antigen is diluted to 10 μ g/mL, every hole adds 100 μ L, and 4 DEG C are spent the night, and incline coating buffer, every hole adds 250 μ L cleansing solutions and washs 3 times, pat dry, then every hole adds confining liquid 250 μ L, hatches 1h for 37 DEG C, incline liquid in hole, cleansing solution washs 3 times, pats dry, and preserves with masking foil vacuum seal.
Embodiment
4, the application of the chemiluminescence enzyme linked immunoassay reagent kit of carbendazim is detected
(1) preparation of reagent
A. sample diluting liquid: use after the concentrated phosphoric acid salt buffer solution distilled water diluting 10 times provided in kit;
B. wash solution: use after the concentrated cleaning solution distilled water diluting 10 times provided in kit;
C. luminescent solution: three (methylol) aminomethane solution (pH8.8)+3/10000 (volume ratio) H of 0.01M luminol+0.001M p-cresol 2o 2.
(2) sample pre-treatments
A, get 20g sample, be placed in 250mL triangular flask through tissue mashing homogenate;
B, add 40mL acetone, ultrasound wave extracts 30min, adds 16g anhydrous sodium sulfate, concussion vortex 1min;
C, room temperature centrifugal more than 4000r/min, 10min;
D., get 5ml supernatant in centrifuge tube, add 5mL methylene chloride, mix in the container of sealing, concussion vortex 1min, room temperature centrifugal more than 4000r/min, 10min;
E, get 1mL supernatant, the sample diluting liquid added after 1mL dilution fully vibrates mixing 30s, mixes to be measured.
(3) detecting step
A, application of sample: in ELISA Plate micropore, add carbendazim series standard strength solution or the molten 50 μ L of sample, then add carbendazim antibody-solutions 50 μ L, room temperature (25 DEG C) constant-temperature incubation 2.5h;
B, washing: incline the middle liquid that portals, every hole adds wash solution 250 μ L, washs 3 times, pats dry;
C, enzyme-added mark goat anti-rabbit antibody solution: every hole adds enzyme mark goat anti-rabbit antibody solution 100 μ L, room temperature constant-temperature incubation 1h;
D, washing: incline the middle liquid that portals, every hole adds wash solution 250 μ L, washs 3 times, pats dry;
E, add luminescent solution: every hole adds luminescent solution 100 μ L;
F, detection: the luminous intensity measuring every hole with chemical illumination immunity analysis instrument.
(4) result judges
The mean value of the standard items obtained and sample luminous value is multiplied by 100 again divided by the luminous value of first standard (0 standard), take inhibiting rate as ordinate, the logarithm of carbendazim concentration is that horizontal ordinate makes typical curve, and the concentration of each sample can read from typical curve.
Inhibiting rate (%)=standard items luminous value (or sample) × 100%/0 standard items luminous value.
Embodiment 5 kit preci-sion and accuracy is tested
Get 0mg/kg, the carbendazim standard specimen of 0.01mg/kg, 0.03mg/kg, 0.09mg/kg, 0.27mg/kg and 0.81mg/kg, adds in agricultural sample, detects the carbendazim recovery.The interassay coefficient of variation of each concentration calculates with 5 repeating datas of different 5 days, and variation within batch coefficient calculates with time repeating data of 5 on the same day.
The quantitative calculating of the recovery is carried out according to the linear equation of the typical curve formulated.
From said determination result, the coefficient of variation lower than 20%, between recovery 80-115%.Show that this kit has well repeatability and accuracy.

Claims (9)

1. a chemical luminescence ELISA detection kit for carbendazim, comprises box body, the reagent being located at the ELISA Plate in box body and being located in box body; It is characterized in that, each hole of described ELISA Plate is coated with the envelope antigen made with carbendazim parent nucleus and ovalbumin coupling; Described reagent comprises: the sheep anti-mouse antibody of carbendazim class monoclonal antibody, horseradish peroxidase-labeled, carbendazim class series standard solution, concentrated phosphoric acid salt buffer, concentrated cleaning solution, chemical luminescence for liquid.
2. the chemical luminescence ELISA detection kit of carbendazim class according to claim 1, is characterized in that: described ELISA Plate is milky opaque polystyrene 96 hole chemiluminescence ELISA Plate.
3. the chemical luminescence ELISA detection kit of carbendazim class according to claim 1, is characterized in that: described envelope antigen concentration is 10 μ g/mL.
4. the chemical luminescence ELISA detection kit of carbendazim class according to claim 1, is characterized in that: the working concentration of described carbendazim monoclonal antibody is 1: 64000.
5. the chemical luminescence ELISA detection kit of carbendazim class according to claim 1, is characterized in that: the monoclonal antibody of described carbendazim is that the conjugate be made up of carbendazim parent nucleus and bovine serum albumin coupling prepares as immunogen immune Balb/c mouse.
6. the chemical luminescence ELISA detection kit of carbendazim according to claim 1, is characterized in that: described carbendazim series standard solution concentration is respectively: 0mg/kg, 0.01mg/kg, 0.03mg/kg, 0.09mg/kg, 0.27mg/kg and 0.81mg/kg.
7. the chemical luminescence ELISA detection kit of carbendazim according to claim 1, is characterized in that: described concentrated phosphoric acid salt buffer be often liter containing NaH 2pO 42H 2o5.74g, Na 2hPO 412H 2the aqueous solution of O32.6g.
8. the chemical luminescence ELISA detection kit of carbendazim according to claim 1, is characterized in that: described thickening and washing solution is the pH=7.4 containing volume fraction 0.05% Tween-20,0.1mol/L phosphate buffer.
9. the chemical luminescence ELISA detection kit of carbendazim class according to claim 1, is characterized in that: three (methylol) aminomethane solution that described chemical luminescence for liquid A liquid is luminol content is 0.01M, p-cresol content is 0.001MpH8.8; B liquid is that 100mL solution contains citric acid 2.1g, anhydrous Na 2hPO 4the solution of 2.82g, the carbamide peroxide 0.64mL of 0.75%, described number percent is mass percent.
CN201410552523.7A 2014-10-17 2014-10-17 Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim Pending CN105572347A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410552523.7A CN105572347A (en) 2014-10-17 2014-10-17 Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410552523.7A CN105572347A (en) 2014-10-17 2014-10-17 Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim

Publications (1)

Publication Number Publication Date
CN105572347A true CN105572347A (en) 2016-05-11

Family

ID=55882712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410552523.7A Pending CN105572347A (en) 2014-10-17 2014-10-17 Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim

Country Status (1)

Country Link
CN (1) CN105572347A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675463A (en) * 2011-03-10 2012-09-19 中华人民共和国北京出入境检验检疫局 Carbendazim monoclonal antibody, preparation method and application thereof
CN103018454A (en) * 2011-09-21 2013-04-03 北京勤邦生物技术有限公司 Sulfanilamide drug chemiluminescence enzyme-linked immunodetection kit
CN103018450A (en) * 2011-09-20 2013-04-03 北京勤邦生物技术有限公司 Chloramphenicol chemiluminescence enzyme-linked immunodetection kit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102675463A (en) * 2011-03-10 2012-09-19 中华人民共和国北京出入境检验检疫局 Carbendazim monoclonal antibody, preparation method and application thereof
CN103018450A (en) * 2011-09-20 2013-04-03 北京勤邦生物技术有限公司 Chloramphenicol chemiluminescence enzyme-linked immunodetection kit
CN103018454A (en) * 2011-09-21 2013-04-03 北京勤邦生物技术有限公司 Sulfanilamide drug chemiluminescence enzyme-linked immunodetection kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王国霞: "多菌灵酶联免疫分析技术研究", 《中国农业科学院硕士学位论文》 *

Similar Documents

Publication Publication Date Title
CN103018454B (en) A kind of chemical luminescence ELISA detection kit of sulfa drugs
CN102422160B (en) Method for measurement of equol in biological sample by immunoassay, kit for the measurement, and method for determination of equol production ability of subject
CN103575890A (en) Chemiluminescence assay kit of ractopamine (RAC) and application thereof
CN101799472A (en) Diethylstilbestrol detection kit and detection method
CN109307761A (en) A kind of indirect competitive ELISA method detecting chaff propylhomoser
CN101446588A (en) Chemiluminescent enzyme-linked immunosorbent assay (CELISA) kit for detecting ractopamine
CN105572348B (en) Detect enzyme linked immunological kit and its application of Triadimenol
CN104655844A (en) Chemiluminescence enzyme-linked immunoassay method used for detecting thiophanate
CN103288872A (en) Methyl parathion hapten, and preparation method and application thereof
CN1971279B (en) Oxoquinoxaline-2-carboxylic acid remained enzyme linked immunity detecting method and reagent kits
CN105675858B (en) Detect enzyme linked immunological kit and its application of dichloro quinolinic acid
CN101368953A (en) Chemical luminescence ELISA detection reagent kit of ciprofloxacin
CN104655614A (en) Chemical-luminescent ELISA method for detecting chlortoluron
CN104655834A (en) Chemical-luminescent enzyme-linked immunoassay method for detecting bentazone
CN105572344A (en) Chemiluminescent enzyme-linked immunoassay method for detecting diclazuril
CN105510576A (en) Chemiluminescence enzyme-linked immunoassay for detecting imidacloprid
CN103645322B (en) A kind of chemical luminescence ELISA detection kit of streptomysin
CN109053477A (en) A kind of preparation method and application of butralin haptens and antigen
CN101135683B (en) Bifenthrin antigen, antibody and uses thereof
CN105277688A (en) Chemiluminescent enzyme-linked immunoassay method for detecting chlorpromazine
CN101446589A (en) Chemiluminescent enzyme-linked immunosorbent assay (CELISA) kit for detecting salbutamol
CN104597238B (en) A kind of mycophenolic acid homogeneous enzyme immunoassay detectable and preparation thereof and detection method
CN104897651A (en) Chemiluminescent kit for aflatoxin M1 and application thereof
CN105572347A (en) Chemiluminiscence enzyme-linked immunoassay method for detecting carbendazim
CN105301244B (en) Detect enzyme linked immunological kit and its application of acid orange

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160511

WD01 Invention patent application deemed withdrawn after publication